Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Veliparib

EU orphan designation number: EU/3/10/830   
Active ingredient: Veliparib
Indication: Treatment of ovarian cancer
Sponsor: AbbVie Ltd
Abbvie House, Vanwall Business Park, Vanwall Road, Maidenhead, SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Orphan designation EMA/OD/110/10 (2010)9543 of 17/12/2010
01/02/2013 Transfer of orphan designation EMA/OD/110/10/T/01 (2013)598 of 30/01/2013
18/01/2016 Change of name and/or address of sponsor